| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amanitins and their development as a payload for antibody-drug conjugates
|
Pahl, Andreas
|
|
2018
|
30 |
C |
p. 85-89
|
artikel
|
| 2 |
Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy
|
Johnston, Michael C.
|
|
2018
|
30 |
C |
p. 63-69
|
artikel
|
| 3 |
Antibody – Drug conjugates (ADC) – Drug discovery today: Technologies
|
Chudasama, Vijay
|
|
2018
|
30 |
C |
p. 1-2
|
artikel
|
| 4 |
Bispecifics and antibody–drug conjugates: A positive synergy
|
Maruani, Antoine
|
|
2018
|
30 |
C |
p. 55-61
|
artikel
|
| 5 |
Drawing lessons from the clinical development of antibody-drug conjugates
|
Lyon, Robert
|
|
2018
|
30 |
C |
p. 105-109
|
artikel
|
| 6 |
Enzymatic strategies for (near) clinical development of antibody-drug conjugates
|
van Berkel, Sander S.
|
|
2018
|
30 |
C |
p. 3-10
|
artikel
|
| 7 |
Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery
|
Richards, Daniel A.
|
|
2018
|
30 |
C |
p. 35-46
|
artikel
|
| 8 |
Homogeneous antibody-drug conjugates via site-selective disulfide bridging
|
Forte, Nafsika
|
|
2018
|
30 |
C |
p. 11-20
|
artikel
|
| 9 |
Miniaturised ‘antibody’-drug conjugates for solid tumours?
|
Deonarain, Mahendra P.
|
|
2018
|
30 |
C |
p. 47-53
|
artikel
|
| 10 |
Minireview: Addressing the retro-Michael instability of maleimide bioconjugates
|
Szijj, Peter A.
|
|
2018
|
30 |
C |
p. 27-34
|
artikel
|
| 11 |
Recent, non-classical, approaches to antibody lysine modification
|
Chaubet, Guilhem
|
|
2018
|
30 |
C |
p. 21-26
|
artikel
|
| 12 |
Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals
|
Morais, Mauricio
|
|
2018
|
30 |
C |
p. 91-104
|
artikel
|
| 13 |
Use of pyrrolobenzodiazepines and related covalent-binding DNA-interactive molecules as ADC payloads: Is mechanism related to systemic toxicity?
|
Jackson, Paul J.M.
|
|
2018
|
30 |
C |
p. 71-83
|
artikel
|
Tijdschrift beschrijving